Display options
Cite
Ramos MJ, Bandiera L, Menolascina F, et al. . iScience. 2021;25(1):103549doi: 10.1016/j.isci.2021.103549.
Ramos, M. J., Bandiera, L., Menolascina, F., & Fallowfield, J. A. (2022). . iScience, 25(1), 103549. https://doi.org/10.1016/j.isci.2021.103549
Ramos, Maria Jimenez, et al. "." iScience vol. 25,1 (2022): 103549. doi: https://doi.org/10.1016/j.isci.2021.103549
Ramos MJ, Bandiera L, Menolascina F, Fallowfield JA. . iScience. 2021 Dec 04;25(1):103549. doi: 10.1016/j.isci.2021.103549. eCollection 2022 Jan 21. PMID: 34977507; PMCID: PMC8689151.
Copy Download .nbib Format: NLM
Share it on

iScience. 2021 Dec 04;25(1):103549. doi: 10.1016/j.isci.2021.103549. eCollection 2022 Jan 21.

[No title available]

iScience

Maria Jimenez Ramos, Lucia Bandiera, Filippo Menolascina, Jonathan Andrew Fallowfield

Affiliations

  1. Centre for Inflammation Research, The University of Edinburgh, The Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.
  2. Institute for Bioengineering, The University of Edinburgh, Edinburgh EH9 3BF, UK.
  3. Synthsys - Centre for Synthetic and Systems Biology, The University of Edinburgh, Edinburgh EH9 3BF, UK.

PMID: 34977507 PMCID: PMC8689151 DOI: 10.1016/j.isci.2021.103549

Abstract

Non-alcoholic fatty liver disease (NAFLD) represents a global healthcare challenge, affecting 1 in 4 adults, and death rates are predicted to rise inexorably. The progressive form of NAFLD, non-alcoholic steatohepatitis (NASH), can lead to fibrosis, cirrhosis, and hepatocellular carcinoma. However, no medical treatments are licensed for NAFLD-NASH. Identifying efficacious therapies has been hindered by the complexity of disease pathogenesis, a paucity of predictive preclinical models and inadequate validation of pharmacological targets in humans. The development of clinically relevant

© 2021 The Author(s).

Keywords: Bioengineering; Cell biology; Cellular physiology

Conflict of interest statement

JA Fallowfield has served as a consultant or advisory board member for Redx Pharma, Novartis, Ferring Pharmaceuticals, Macrophage Pharma, Galecto Biotech, Caldan Therapeutics, Cypralis Ltd, Rallybio,

References

  1. Drug Metab Dispos. 2003 Aug;31(8):1035-42 - PubMed
  2. J Hepatol. 2017 Jan;66(1):212-227 - PubMed
  3. Cell Mol Gastroenterol Hepatol. 2017 Dec 06;5(3):426-439.e1 - PubMed
  4. Biotechnol Bioeng. 2018 Nov;115(11):2817-2827 - PubMed
  5. Adv Healthc Mater. 2019 Dec;8(24):e1901379 - PubMed
  6. Microphysiol Syst. 2020 Jun;4: - PubMed
  7. Proc Soc Exp Biol Med. 1997 Mar;214(3):248-57 - PubMed
  8. Cell Rep. 2017 Dec 5;21(10):2661-2670 - PubMed
  9. J Hepatol. 2014 Oct;61(4):925-43 - PubMed
  10. World J Gastroenterol. 2004 Mar 1;10(5):699-702 - PubMed
  11. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):674-8 - PubMed
  12. Toxicol Sci. 2016 Dec;154(2):354-367 - PubMed
  13. JHEP Rep. 2021 Jan 28;3(3):100237 - PubMed
  14. Gut. 2005 Jan;54(1):142-51 - PubMed
  15. Clin Liver Dis. 2018 Feb;22(1):11-21 - PubMed
  16. J Appl Toxicol. 2019 Mar;39(3):461-472 - PubMed
  17. Hepatol Int. 2019 Jan;13(1):51-57 - PubMed
  18. Toxicol Appl Pharmacol. 2003 Jun 15;189(3):233-46 - PubMed
  19. J Clin Gastroenterol. 2005 Apr;39(4 Suppl 2):S158-61 - PubMed
  20. Tissue Eng. 2004 Sep-Oct;10(9-10):1566-76 - PubMed
  21. J Hepatol. 2018 Feb;68(2):268-279 - PubMed
  22. Nat Mater. 2021 Feb;20(2):145-155 - PubMed
  23. Trends Biotechnol. 2021 Aug;39(8):788-810 - PubMed
  24. Physiol Rep. 2017 Dec;5(24): - PubMed
  25. J Hepatol. 2016 Feb;64(2):399-408 - PubMed
  26. Protein Cell. 2015 Aug;6(8):562-74 - PubMed
  27. STAR Protoc. 2021 Apr 30;2(2):100502 - PubMed
  28. Cancers (Basel). 2021 Feb 19;13(4): - PubMed
  29. Gastroenterology. 2016 May;150(5):1219-1230.e6 - PubMed
  30. J Intern Med. 2020 Jul;288(1):139-151 - PubMed
  31. Hepatology. 2016 Jul;64(1):73-84 - PubMed
  32. Nat Protoc. 2016 Sep;11(9):1724-43 - PubMed
  33. Cell. 2021 May 13;184(10):2537-2564 - PubMed
  34. Chem Biol Interact. 2007 Jan 30;165(2):106-16 - PubMed
  35. Sci Rep. 2019 Aug 12;9(1):11585 - PubMed
  36. PLoS One. 2016 Jul 07;11(7):e0158674 - PubMed
  37. World J Gastroenterol. 2016 Dec 28;22(48):10512-10522 - PubMed
  38. Biotechnol Prog. 1991 May-Jun;7(3):237-45 - PubMed
  39. Metabolism. 2015 Sep;64(9):982-90 - PubMed
  40. Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):223-238 - PubMed
  41. Prog Lipid Res. 2008 Sep;47(5):348-80 - PubMed
  42. World J Gastroenterol. 2018 Jul 7;24(25):2661-2672 - PubMed
  43. Biochem Biophys Res Commun. 2004 Feb 27;315(1):187-95 - PubMed
  44. Arch Toxicol. 2013 Aug;87(8):1315-530 - PubMed
  45. Gastroenterology. 2015 Aug;149(2):367-78.e5; quiz e14-5 - PubMed
  46. Food Funct. 2021 Mar 1;12(4):1829-1840 - PubMed
  47. Sci Rep. 2018 Sep 24;8(1):14297 - PubMed
  48. Hepatology. 2021 Sep;74(3):1271-1286 - PubMed
  49. Ann Surg Treat Res. 2017 Feb;92(2):67-72 - PubMed
  50. Cell Metab. 2019 Aug 6;30(2):374-384.e6 - PubMed
  51. J Gastroenterol. 2018 Dec;53(12):1285-1291 - PubMed
  52. Front Bioeng Biotechnol. 2020 Jul 22;8:762 - PubMed
  53. Retrovirology. 2008 Jan 04;5:1 - PubMed
  54. Cells. 2020 Apr 14;9(4): - PubMed
  55. Cell Mol Gastroenterol Hepatol. 2021;12(4):1297-1310 - PubMed
  56. Hepatology. 2010 May;51(5):1754-65 - PubMed
  57. Gut Liver. 2017 Jan 15;11(1):121-128 - PubMed
  58. Nat Biotechnol. 2014 Aug;32(8):773-85 - PubMed
  59. World J Gastroenterol. 2014 Dec 28;20(48):18070-91 - PubMed
  60. Biofabrication. 2016 Jan 12;8(1):014101 - PubMed
  61. Adv Healthc Mater. 2020 Dec;9(24):e2001517 - PubMed
  62. Syst Rev. 2019 Nov 29;8(1):295 - PubMed
  63. Nutrients. 2017 Jul 14;9(7): - PubMed
  64. Toxicol In Vitro. 2004 Aug;18(4):527-32 - PubMed
  65. J Clin Exp Hepatol. 2020 May-Jun;10(3):211-221 - PubMed
  66. Gastroenterology. 2020 Oct;159(4):1471-1486.e12 - PubMed
  67. Science. 2019 Aug 2;365(6452): - PubMed
  68. Adv Drug Deliv Rev. 2017 Nov 1;121:133-146 - PubMed
  69. Cloning Stem Cells. 2007 Spring;9(1):51-62 - PubMed
  70. JCI Insight. 2016 Dec 8;1(20):e90954 - PubMed
  71. Transplant Proc. 2013 Mar;45(2):695-700 - PubMed
  72. Int Immunopharmacol. 2014 Nov;23(1):37-45 - PubMed
  73. Cells. 2019 Dec 12;8(12): - PubMed
  74. PLoS One. 2013 Oct 08;8(10):e75692 - PubMed
  75. Horm Mol Biol Clin Investig. 2018 Aug 11;41(1): - PubMed
  76. Acta Biomater. 2021 Oct 15;134:228-239 - PubMed
  77. Cell Syst. 2021 Jan 20;12(1):41-55.e11 - PubMed
  78. PLoS One. 2017 Feb 2;12(2):e0171215 - PubMed
  79. J Lipid Res. 2009 Oct;50(10):2111-6 - PubMed
  80. iScience. 2020 Dec 11;24(1):101931 - PubMed
  81. Antioxid Redox Signal. 2017 Aug 1;27(4):201-214 - PubMed
  82. Biotechnol Bioeng. 2021 Jan;118(1):142-152 - PubMed
  83. Hepatol Commun. 2020 Jul 08;4(9):1316-1331 - PubMed
  84. Hepatology. 2021 Oct;74(4):1825-1844 - PubMed
  85. Trends Pharmacol Sci. 2011 Feb;32(2):72-81 - PubMed
  86. Clin Gastroenterol Hepatol. 2019 May;17(6):1040-1060.e11 - PubMed
  87. Toxicol Sci. 2018 Apr 1;162(2):655-666 - PubMed
  88. Am J Physiol Endocrinol Metab. 2015 Sep 15;309(6):E511-22 - PubMed
  89. Environ Toxicol. 2021 Feb;36(2):168-176 - PubMed
  90. Toxicol In Vitro. 2017 Mar;39:93-103 - PubMed
  91. Cell Stem Cell. 2018 Jul 05;23(1):101-113.e7 - PubMed
  92. In Vitro Cell Dev Biol Anim. 1997 Jun;33(6):467-72 - PubMed
  93. Toxicol In Vitro. 2011 Oct;25(7):1501-6 - PubMed
  94. Toxicol Sci. 2021 Apr 27;181(1):90-104 - PubMed
  95. Toxicol In Vitro. 2007 Feb;21(1):157-64 - PubMed
  96. Gut. 2021 Jan;70(1):180-193 - PubMed
  97. Toxicol In Vitro. 2007 Jun;21(4):545-57 - PubMed
  98. J Immunol Methods. 2018 Apr;455:71-79 - PubMed
  99. Mol Med Rep. 2020 Aug;22(2):939-947 - PubMed
  100. Clin Ther. 2021 Mar;43(3):500-517 - PubMed
  101. Tissue Eng Part B Rev. 2017 Jun;23(3):237-244 - PubMed
  102. Rev Recent Clin Trials. 2014;9(3):141-7 - PubMed
  103. J Hepatol. 2018 Oct;69(4):896-904 - PubMed
  104. Toxicol Sci. 2010 May;115(1):66-79 - PubMed
  105. Pharmacotherapy. 2021 Mar;41(3):315-328 - PubMed
  106. Gastroenterology. 2020 Nov;159(5):1853-1865.e10 - PubMed
  107. Aliment Pharmacol Ther. 2018 Oct;48(7):696-703 - PubMed
  108. Front Bioeng Biotechnol. 2021 Feb 16;8:536957 - PubMed
  109. Nat Genet. 2014 Apr;46(4):352-6 - PubMed
  110. Tissue Eng Part C Methods. 2015 Apr;21(4):413-22 - PubMed
  111. PLoS One. 2018 Jun 11;13(6):e0198943 - PubMed
  112. Nat Biotechnol. 2014 Aug;32(8):760-72 - PubMed
  113. Nat Rev Mol Cell Biol. 2020 Oct;21(10):571-584 - PubMed
  114. Hepatol Int. 2020 Jan;14(1):8-23 - PubMed
  115. Diabetes Care. 2018 Jun;41(6):1235-1243 - PubMed
  116. Diabetol Metab Syndr. 2020 Jul 14;12:60 - PubMed
  117. Sci Rep. 2016 May 04;6:25187 - PubMed
  118. Cancers (Basel). 2020 Sep 23;12(10): - PubMed
  119. ACS Pharmacol Transl Sci. 2020 Dec 08;4(1):101-106 - PubMed
  120. Curr Drug Metab. 2003 Aug;4(4):292-312 - PubMed
  121. Biomed Res Int. 2015;2015:460190 - PubMed
  122. J Clin Med. 2020 Dec 24;10(1): - PubMed
  123. Life Sci. 2010 Sep 25;87(13-14):431-8 - PubMed
  124. Lab Chip. 2016 Jul 5;16(14):2618-25 - PubMed
  125. Hepatology. 2009 Jul;50(1):56-67 - PubMed
  126. Int J Mol Sci. 2020 Jul 23;21(15): - PubMed
  127. Nat Genet. 2008 Dec;40(12):1461-5 - PubMed
  128. Adipocyte. 2019 Dec;8(1):83-97 - PubMed
  129. Philos Trans R Soc Lond B Biol Sci. 2018 Jul 5;373(1750): - PubMed
  130. J Korean Surg Soc. 2013 Apr;84(4):202-8 - PubMed
  131. Crit Rev Food Sci Nutr. 2019;59(22):3648-3666 - PubMed
  132. Biotechnol Bioeng. 2008 Feb 1;99(2):399-410 - PubMed
  133. JHEP Rep. 2020 Oct 22;3(1):100198 - PubMed
  134. Diabetes Obes Metab. 2021 May;23(5):1069-1083 - PubMed
  135. Biofabrication. 2020 Feb 26;12(2):025017 - PubMed
  136. CSH Protoc. 2008 Dec 01;2008:pdb.prot5080 - PubMed
  137. Hepatology. 2010 Sep;52(3):894-903 - PubMed
  138. Cell Biol Toxicol. 2017 Aug;33(4):407-421 - PubMed
  139. Nat Rev Dis Primers. 2015 Dec 17;1:15080 - PubMed
  140. Int J Mol Sci. 2020 Jan 11;21(2): - PubMed
  141. Mol Biol Rep. 2020 Oct;47(10):8331-8337 - PubMed
  142. Sci Rep. 2020 Feb 3;10(1):1699 - PubMed
  143. Cell. 2007 Nov 30;131(5):861-72 - PubMed
  144. Adv Healthc Mater. 2021 Jan;10(2):e2001284 - PubMed
  145. Life (Basel). 2021 Aug 21;11(8): - PubMed
  146. Hepatol Commun. 2019 Nov 13;4(1):77-91 - PubMed
  147. Hepatology. 2010 Apr;51(4):1209-17 - PubMed
  148. Am J Physiol Gastrointest Liver Physiol. 2013 Oct 1;305(7):G483-95 - PubMed
  149. Compr Physiol. 2013 Jan;3(1):243-87 - PubMed
  150. Front Immunol. 2021 Jun 11;12:678360 - PubMed
  151. Am J Pathol. 2010 Jul;177(1):153-65 - PubMed
  152. J Cell Biochem. 2007 Jun 1;101(3):723-34 - PubMed
  153. Cells. 2020 Oct 07;9(10): - PubMed
  154. Int J Mol Sci. 2019 Apr 02;20(7): - PubMed
  155. World J Gastroenterol. 2020 Sep 14;26(34):5101-5117 - PubMed
  156. Stem Cell Reports. 2014 Jun 12;3(1):5-14 - PubMed
  157. J Natl Cancer Inst. 1971 Jan;46(1):113-20 - PubMed
  158. Biochemistry (Mosc). 2013 Feb;78(2):111-26 - PubMed
  159. Biochem Biophys Rep. 2017 Apr 14;10:186-191 - PubMed
  160. Toxicol In Vitro. 2008 Sep;22(6):1618-31 - PubMed
  161. Biotechnol Prog. 1998 May-Jun;14(3):378-87 - PubMed
  162. Biol Open. 2020 Dec 16;9(12): - PubMed
  163. Nat Commun. 2016 Jan 06;7:10243 - PubMed
  164. Biomol Ther (Seoul). 2020 Nov 1;28(6):527-536 - PubMed
  165. Toxicol Res (Camb). 2016 Jun 1;5(4):1053-1065 - PubMed
  166. Biochem Biophys Res Commun. 2019 Apr 9;511(3):524-530 - PubMed
  167. Small. 2021 Apr;17(14):e2007425 - PubMed
  168. Organogenesis. 2018 Jan 2;14(1):1-12 - PubMed
  169. PLoS One. 2016 Jul 20;11(7):e0159729 - PubMed
  170. Dis Model Mech. 2018 Sep 25;11(9): - PubMed
  171. Sci Rep. 2021 Jun 23;11(1):13159 - PubMed
  172. J Clin Invest. 2005 May;115(5):1343-51 - PubMed
  173. FASEB J. 1996 Nov;10(13):1471-84 - PubMed
  174. Exp Biol Med (Maywood). 2016 Sep;241(15):1684-98 - PubMed
  175. Stem Cells Dev. 2016 Aug 1;25(15):1119-33 - PubMed
  176. J Lipid Res. 2000 Jun;41(6):882-93 - PubMed
  177. BMC Gastroenterol. 2020 Jul 6;20(1):210 - PubMed
  178. Cells. 2019 Dec 21;9(1): - PubMed
  179. Toxicol In Vitro. 2015 Oct;29(7):1753-8 - PubMed
  180. Hepatol Commun. 2020 Nov 29;5(2):217-233 - PubMed
  181. Toxicol Mech Methods. 2020 Mar;30(3):189-196 - PubMed
  182. Biomaterials. 2020 Apr;237:119823 - PubMed
  183. Hepatology. 2015 Jan;61(1):15-7 - PubMed
  184. Drug Metab Dispos. 2018 Nov;46(11):1626-1637 - PubMed
  185. Expert Opin Emerg Drugs. 2021 Jun;26(2):149-163 - PubMed
  186. Mol Metab. 2021 Aug;50:101122 - PubMed

Publication Types